Not so Nutsy Professer, as i understand it Jeff from Yahoo board has been a long time GVAX proponent. Obviously I concur with his assessment. I believe the coverage from the Lancet could attract more well healed and well informed investors which should put some upward pressure on the share price before Libigel info comes out.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.